Sign in
4

Changes in Ownership

Moleculin Biotech, Inc. Filed Acc 0001144204-18-033605

Options or other derivatives

  • CEO and President acquired 603,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
KLEMP WALTER V CEO and President 2018-06-06 Grant or award · Stock option (right to buy) +603,000 943,000 D: show line 1 in the form
Loading xslF345X03/tv496089_4.xml…